Prospective study on the role of glucose metabolism in breast cancer occurrence

International Journal of Cancer

Volumn 130, Issue 4, 2012, Pages 921-929

  Sieri, Sabina ^a   Muti, Paola ^b   Claudia, Agnoli ^a   Berrino, Franco ^a   Pala, Valeria ^a   Grioni, Sara ^a   Abagnato, Carlo Alberto ^c   Blandino, Giovanni ^b   Contiero, Paolo ^a   Schunemann, Holger J ^d   Krogh, Vittorio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c Centro Medico Diagnostico Emilia   (Italy)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

breast cancer; cohort study; glucose; insulin

Indexed keywords

GLUCOSE; INSULIN; SEX HORMONE BINDING GLOBULIN;

ADULT; BREAST CANCER; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HOMEOSTASIS MODEL ASSESSMENT INSULIN RESISTANCE INDEX; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW;

ADULT; AGED; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GLUCOSE; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; PROSPECTIVE STUDIES; SEX HORMONE-BINDING GLOBULIN;

EID: 83955165955     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26071     Document Type: Review

References (46)

1. Helmlinger G, Yuan F, Dellian M, Jain RK,. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 1997; 3: 177-82. (Pubitemid 27064702)
2. Gatenby RA,. The potential role of transformation-induced metabolic changes in tumor-host interaction. Cancer Res 1995; 55: 4151-6.
3. Dang CV, Semenza GL,. Oncogenic alterations of metabolism. Trends Biochem Sci 1999; 24: 68-72. (Pubitemid 29346576)
4. Warburg O,. On the origin of cancer cells. Science 1956; 123: 309-14.
5. Reaven GM,. Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension. Parallels between human disease and rodent models. Diabetes Care 1991; 14: 195-202.
6. Nestler JE,. Obesity, insulin, sex steroids and ovulation. Int J Obes Relat Metab Disord 2000; 24 Suppl 2: S71-3. (Pubitemid 30461952)
7. Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC,. The insulin-related ovarian regulatory system in health and disease. Endocr Rev 1999; 20: 535-82. (Pubitemid 30647079)
8. Stattin P, Bjor O, Ferrari P, Lukanova A, Lenner P, Lindahl B, Hallmans G, Kaaks R,. Prospective study of hyperglycemia and cancer risk. Diabetes Care 2007; 30: 561-7. (Pubitemid 46354334)
9. Rapp K, Schroeder J, Klenk J, Ulmer H, Concin H, Diem G, Oberaigner W, Weiland SK,. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 2006; 49: 945-52.
10. Bjorge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, Stocks T, Selmer R, Nagel G, Almquist M, Concin H, Hallmans G, et al,. Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev 2010; 19: 1737-45.
11. Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schunemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M, Berrino F,. Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2002; 11: 1361-8. (Pubitemid 35340370)
12. Manjer J, Kaaks R, Riboli E, Berglund G,. Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmo Preventive Project. Eur J Cancer Prev 2001; 10: 33-42. (Pubitemid 32200200)
13. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM,. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293: 194-202. (Pubitemid 40095870)
14. Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR,. Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 2002; 156: 349-52. (Pubitemid 34858003)
15. Kabat GC, Kim M, Caan BJ, Chlebowski RT, Gunter MJ, Ho GY, Rodriguez BL, Shikany JM, Strickler HD, Vitolins MZ, Rohan TE,. Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer 2009; 125: 2704-10.
16. Pisani P,. Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem 2008; 114: 63-70. (Pubitemid 351998745)
17. Verheus M, Peeters PH, Rinaldi S, Dossus L, Biessy C, Olsen A, Tjonneland A, Overvad K, Jeppesen M, Clavel-Chapelon F, Tehard B, Nagel G, et al,. Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2006; 119: 659-67. (Pubitemid 43955721)
18. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL, Kaplan RC, Harris TG, et al,. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2009; 101: 48-60.
19. Key T, Appleby P, Barnes I, Reeves G,. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002; 94: 606-16. (Pubitemid 34498648)
20. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, Dossus L, Lukanova A, Bingham S, Khaw KT, Allen NE, Bueno-de-Mesquita HB, et al,. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 2005; 12: 1071-82. (Pubitemid 41815798)
21. Preziosi P, Barrett-Connor E, Papoz L, Roger M, Saint-Paul M, Nahoul K, Simon D,. Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: the telecom study. J Clin Endocrinol Metab 1993; 76: 283-7. (Pubitemid 23073042)
22. Nestler JE,. Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance? J Clin Endocrinol Metab 1993; 76: 273-4. (Pubitemid 23073039)
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC,. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9. (Pubitemid 15018832)
24. Berrino F, Muti P, Micheli A, Bolelli G, Krogh V, Sciajno R, Pisani P, Panico S, Secreto G,. Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 1996; 88: 291-6. (Pubitemid 26073374)
25. Sieri S, Krogh V, Muti P, Micheli A, Pala V, Crosignani P, Berrino F,. Fat and protein intake and subsequent breast cancer risk in postmenopausal women. Nutr Cancer 2002; 42: 10-7. (Pubitemid 35007001)
26. Levy JC, Matthews DR, Hermans MP,. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998; 21: 2191-2. (Pubitemid 28549174)
27. Nicolucci A,. Epidemiological aspects of neoplasms in diabetes. Acta Diabetol 2010; 47: 87-95.
28. Gatenby RA, Gillies RJ,. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004; 4: 891-9. (Pubitemid 39472955)
29. Larsson SC, Mantzoros CS, Wolk A,. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 2007; 121: 856-62. (Pubitemid 47106217)
30. Toniolo P, Bruning PF, Akhmedkhanov A, Bonfrer JM, Koenig KL, Lukanova A, Shore RE, Zeleniuch-Jacquotte A,. Serum insulin-like growth factor-I and breast cancer. Int J Cancer 2000; 88: 828-32.
31. Eliassen AH, Tworoger SS, Mantzoros CS, Pollak MN, Hankinson SE,. Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Cancer Epidemiol Biomarkers Prev 2007; 16: 161-4. (Pubitemid 46174280)
32. Ikeda Y, Niimi M, Kan S, Shatari T, Takami H, Kodaira S,. Clinical significance of tissue blood flow during esophagectomy by laser Doppler flowmetry. J Thorac Cardiovasc Surg 2001; 122: 1101-6.
33. Agnoli C, Berrino F, Abagnato CA, Muti P, Panico S, Crosignani P, Krogh V,. Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis 2010; 20: 41-8.
34. Golden SH, Dobs AS, Vaidya D, Szklo M, Gapstur S, Kopp P, Liu K, Ouyang P,. Endogenous sex hormones and glucose tolerance status in postmenopausal women. J Clin Endocrinol Metab 2007; 92: 1289-95. (Pubitemid 46556400)
35. Haffner SM, Dunn JF, Katz MS,. Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women. Metabolism 1992; 41: 278-84.
36. Goodman-Gruen D, Barrett-Connor E,. Sex hormone-binding globulin and glucose tolerance in postmenopausal women. The Rancho Bernardo Study. Diabetes Care 1997; 20: 645-9. (Pubitemid 27143431)
37. Ding EL, Song Y, Malik VS, Liu S,. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006; 295: 1288-99.
38. Sherif K, Kushner H, Falkner BE,. Sex hormone-binding globulin and insulin resistance in African-American women. Metabolism 1998; 47: 70-4. (Pubitemid 28086235)
39. McTernan PG, Anwar A, Eggo MC, Barnett AH, Stewart PM, Kumar S,. Gender differences in the regulation of P450 aromatase expression and activity in human adipose tissue. Int J Obes Relat Metab Disord 2000; 24: 875-81. (Pubitemid 30449923)
40. Tsugane S, Inoue M,. Insulin resistance and cancer: epidemiological evidence. Cancer Sci 2010.
41. Sieri S, Krogh V, Bolelli G, Abagnato CA, Grioni S, Pala V, Evangelista A, Allemani C, Micheli A, Tagliabue G, Schunemann HJ, Menard S, et al,. Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev 2009; 18: 169-76.
42. Cullen KJ, Lippman ME,. Estrogen regulation of protein synthesis and cell growth in human breast cancer. Vitam Horm 1989; 45: 127-72.
43. Milazzo G, Giorgino F, Damante G, Sung C, Stampfer MR, Vigneri R, Goldfine ID, Belfiore A,. Insulin receptor expression and function in human breast cancer cell lines. Cancer Res 1992; 52: 3924-30.
44. Webster NJ, Resnik JL, Reichart DB, Strauss B, Haas M, Seely BL,. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer. Cancer Res 1996; 56: 2781-8. (Pubitemid 26175738)
45. Papa V, Costantino A, Belfiore A,. Insulin receptor what role in breast cancer? Trends Endocrinol Metab 1997; 8: 306-12. (Pubitemid 27516732)
46. Alberti KG, Zimmet PZ,. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-53. (Pubitemid 28319935)